Open Systems Pharmacology Community Conference ( <scp>OSP</scp> ‐ <scp>CC</scp> ) Proceedings 2025

Developed at Bayer Technology Services, PK-Sim and MoBi transitioned into the Open Systems Pharmacology (OSP) Suite, released as free open-source software in 2017. An active community with stakeholders from academia, industries, and regulators contributes to the continuous improvement of open-source model-informed drug development (MIDD). This perspective summarizes the latest advancements presented at the second OSP Community Conference (OSP-CC) hosted from 29 to 30th of September 2025 at Sanofi Paris, that gathered over 100 attendees from more than 40 institutions.

Authors

Institutions

Publication Details

Journal
CPT Pharmacometrics & Systems Pharmacology
Published
2026-02-21
DOI
https://doi.org/10.1002/psp4.70217
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Open Systems Pharmacology Community Conference ( OSP ‐ CC ) Proceedings 2025

Florence Gattacceca, Rodolfo Hernandes Bonan, Tobias Kanacher, Yunhai Cui et al.
CPT Pharmacometrics & Systems Pharmacology
Computational Drug Discovery Methods
article

Open Systems Pharmacology Community Conference ( OSP ‐ CC ) Proceedings 2025

Florence Gattacceca, Rodolfo Hernandes Bonan, Tobias Kanacher, Yunhai Cui, Mariana P. Guimarães, Nina Nauwelaerts, Stephan Schaller, Donato Teutonico, Salih Benamara, Abdullah Hamadeh, Ghazal Montaseri, Lars Kuepfer, René Geci, Marylore Chenel, Andrea Grüber, Jan Schlender, Henrik Cordes, Grégori Gerebtzoff, Ibrahim Ince, Pavel Balazki, Annika R. P. Schneider, Erik Sjögren, André Dallmann, Denise Feick, Paul Vrenken, Cleo Demeester, Wilhelmus E. A. de Witte, N. Hanke, Manuel Ibarra, Susana Proenca, Alexander Staab, Pieter Annaert, Juri Solodenko, Carla Troisi, Felix Mil, Andrew Butler
article en

Abstract

Developed at Bayer Technology Services, PK-Sim and MoBi transitioned into the Open Systems Pharmacology (OSP) Suite, released as free open-source software in 2017. An active community with stakeholders from academia, industries, and regulators contributes to the continuous improvement of open-source model-informed drug development (MIDD). This perspective summarizes the latest advancements presented at the second OSP Community Conference (OSP-CC) hosted from 29 to 30th of September 2025 at Sanofi Paris, that gathered over 100 attendees from more than 40 institutions.

CPT Pharmacometrics & Systems PharmacologyVol. 15(3)
Uppsala University (SE), Novartis (Switzerland) (CH), Centre National de la Recherche Scientifique (FR), Thorlabs (Germany) (DE), Boehringer Ingelheim (Germany) (DE), University of Waterloo (CA), Inserm (FR), Universidad de la República de Uruguay (UY), National and Kapodistrian University of Athens (GR), Aix-Marseille Université (FR), Sanofi (France) (FR), Centre Inria d'Université Côte d'Azur (FR), Sanofi (Germany) (DE), Bayer (France) (FR), Bayer (Germany) (DE), RWTH Aachen University (DE), KU Leuven (BE)
Partnerships for the goals
Openalex Percentile: Top 46%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.